TigerConnect extends patient communication platform, tools during coronavirus pandemic Originally posted in BeckersHospitalReview.com by Jackie Drees (March 13, 2020) TigerConnect, a clinical communication platform, is offering U.S. hospitals and health systems free...
Iterum Therapeutics Announces $52 Million Private Placement with New and Existing Investors DUBLIN, Ireland and CHICAGO, Jan. 17, 2020 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical company focused on...
Deciphera Pharmaceuticals Provides Corporate Update and Highlights Key 2020 Milestones – Ripretinib Marketing Applications Submitted to Health Canada and Australia’s Therapeutic Goods Administration for Patients with Advanced GIST via the U.S. FDA’s Project...
Principia Announces Expanded Development Program to Broaden BTK Footprint in Immune-Mediated Diseases Company’s lead candidate PRN1008 receives generic name — rilzabrutinib Rilzabrutinib to enter clinical trial in IgG4-Related Disease SOUTH SAN FRANCISCO,...
Principia Updates PRN1008 Pemphigus Clinical Program Accelerated enrollment of company’s Phase 3 pivotal trial anticipating final results in second half of 2021 SOUTH SAN FRANCISCO, Calif., Dec. 30, 2019 (GLOBE NEWSWIRE) — Principia Biopharma Inc. (Nasdaq:...
Recent Comments